Trial intelligence / Profile preview

Sodium Bicarbonate vs Normal Saline for RCIN Prevention

NCT00514150Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Aug 2007
Primary completion
Jun 2008
Modality
Implantable Devices, Transdermal Patches, Inhalation Devices
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of sodium bicarbonate ringer's solution in contrast-induced nephropathy (CIN) (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Development of Contrast Induced Nephropathy at 48 hours. Started Aug 2007; status: completed.

02

Drugs

sodium bicarbonate ringer's solution
03

Conditions

contrast-induced nephropathy (CIN)

Beyond the preview

Go deeper on NCT00514150.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00514150.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call